共 50 条
- [1] First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastasesARCHIVES OF SURGERY, 2008, 143 (04) : 352 - 358Galizia, GennaroLieto, EvaOrditura, MicheleCastellano, PaoloImperatore, VincenzoPinto, MargheritaZamboli, Anna
- [2] First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer PatientsPLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 285 - 293Vasile, EnricoMasi, GianlucaLoupakis, FotiosCupini, SamantaBaldi, Giacomo GiulioFornaro, LorenzoStasi, IreneSalvatore, LisaFalcone, Alfredo
- [3] Hepatic Arterial Infusion with Irinotecan, Oxaliplatin, and Floxuridine plus Systemic Chemotherapy as First-Line Treatment of Unresectable Liver Metastases from Colorectal CancerONKOLOGIE, 2012, 35 (09): : 480 - 484Chen, YiWang, XiaolinYan, ZhipingWang, JianhuaLuo, JianjunLiu, Qingxin
- [4] Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinomaFRONTIERS IN PHARMACOLOGY, 2023, 14Yang, ZhenyunFu, YizhenWu, WeijieHu, ZiliPan, YangxunWang, JunchengChen, JinbinHu, DandanZhou, ZhongguoChen, MinshanZhang, Yaojun
- [5] First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastasesCANCER BIOLOGY & THERAPY, 2016, 17 (01) : 14 - 19Li, XiaodongShi, LiangrongWu, JunJi, MeiZhao, JieminQiang, WeiguangDing, WengeJiang, JingtingLu, QichengWu, Changping
- [6] Safety profile of first-line bevacizumab and chemotherapy in patients with unresected primary colorectal cancer and synchronous metastasesJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Mello, C.Oliveira, T. B.Paiva, T. F., Jr.Silva, M. J.Sanches, S. M.Cruz, M. R.Nicolau, U. R.Fanelli, M. F.
- [7] Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical TrialJOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (10) : 1098 - +Kanemitsu, YukihideShitara, KoheiMizusawa, JunkiHamaguchi, TetsuyaShida, DaiKomori, KojiIkeda, SatoshiOjima, HitoshiIke, HideyukiShiomi, AkioWatanabe, JunTakii, YasumasaYamaguchi, TakashiKatsumata, KenjiIto, MasaakiOkuda, JunjiHyakudomi, RyojiShimada, YasuhiroKatayama, HiroshiFukuda, Haruhiko
- [8] Early tumor shrinkage as a predictor of favorable outcomes in patients with unresectable metastatic colorectal cancer treated with first-line chemotherapy plus bevacizumabANNALS OF ONCOLOGY, 2020, 31 : S178 - S178Behourah, Z.Ameziane, N.Aida, M.Messaoud, M. AhedBousahba, A.
- [9] Efficacy of first-line radiofrequency ablation combined with systemic chemotherapy plus targeted therapy for initially unresectable colorectal liver metastasesINTERNATIONAL JOURNAL OF HYPERTHERMIA, 2025, 42 (01)Kong, YaqingHuang, XiaoyuPeng, GangCao, XiaojingZhou, Xiang
- [10] Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone as First-Line Therapy for NSCLCJOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S428 - S428Gadgeel, ShirishGandhi, LeenaBorghaei, HosseinSocinski, Mark A.Gubens, Matthew A.Stevenson, JamesSequist, Lecia V.Yang, James Chih-HsinPapadimitrakopoulou, VassilikiBourque, JenniferBachman, Robert D.Ge, Joy YangIm, ElliePatnaik, Amita